Assessment of pediatric residents burnout in a tertiary academic centre

Roaa S Jamjoom1, Yoon S Park

  • 1Paediatric Emergency, King Abdulaziz University Jeddah, Kingdom of Saudi Arabia. E-mail. rsjamjoom@kau.edu.sa.

Saudi Medical Journal
|March 16, 2018
PubMed

Insights

Pediatric residents in Saudi Arabia face significant burnout, with over 70% experiencing severe symptoms. High rates of depersonalization were noted, impacting resident well-being.

Area of Science:

  • Medical Education
  • Occupational Health
  • Pediatrics

Background:

  • Burnout syndrome is a growing concern among healthcare professionals globally.
  • Pediatric residency programs require specific attention due to demanding training environments.
  • Understanding burnout prevalence is crucial for resident well-being and program improvement.

Purpose of the Study:

  • To investigate the prevalence and severity of burnout among pediatric residents.
  • To identify specific dimensions of burnout experienced by these residents.
  • To assess burnout at King Abdulaziz University Hospital in Jeddah, Saudi Arabia.

Main Methods:

  • A cross-sectional survey design was employed.
  • The study included pediatric residents (PGY1-PGY4) at a tertiary academic hospital.
  • Surveys were emailed to 50 registered residents, with a 70% completion rate.

Main Results:

  • Over 70% of pediatric residents reported experiencing severe burnout.
  • Specific burnout dimensions included 43% emotional exhaustion, 71.8% depersonalization, and 40.6% low accomplishment.
  • Depersonalization levels were notably higher compared to national and international peers.

Conclusions:

  • Burnout syndrome poses a significant threat to the well-being of pediatric residents in this program.
  • The high prevalence of depersonalization suggests a critical need for targeted interventions.
  • Findings highlight the importance of addressing burnout to ensure a sustainable pediatric residency program.
Abstract

Related Concept Videos

Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
2.2K
Nomenclature of Secondary and Tertiary Amines01:12

Nomenclature of Secondary and Tertiary Amines

The secondary and tertiary amines are derivatives of ammonia, where two and three of its hydrogens are replaced by alkyl groups, respectively. Secondary and tertiary amines can be symmetrical with identical alkyl groups attached to the nitrogen atom or unsymmetrical when more than one type of alkyl group is present. The standard nomenclature of secondary and tertiary amines is similar to the names given to the primary amines. They are generally named alkylamines. As depicted in Figure 1, for...
5.2K
Noncompartmental Analysis: Mean Residence Time01:05

Noncompartmental Analysis: Mean Residence Time

According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
619
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246